This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Cancer Metabolism and Signaling

Cancer Metabolism and Signaling

Thursday, May 9, 2019

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Cancer Discussion Group

The New York Academy of Sciences


There has been a resurgence of interest in understanding how metabolic pathways are altered in cancer and how these alterations can be exploited for therapeutic gain. Many of the signaling pathways that drive tumorigenesis directly regulate metabolic pathways that support cell growth. Increasingly, metabolites themselves are recognized to play important roles regulating tumor initiation and progression. Beyond providing the building blocks for cell proliferation, metabolites can directly influence stress response pathways, chromatin modifications and gene expression that collectively drive tumor development. This meeting will bring experts together to discuss the intersection between cancer cell signaling and metabolism and explore how cancer cells exploit cellular signaling and metabolic pathways to support malignant growth.


By 03/29/2019
After 03/29/2019
Nonmember Academia, Faculty, etc.
By 03/29/2019
After 03/29/2019
Nonmember Corporate, Other
By 03/29/2019
After 03/29/2019
Nonmember Not for Profit
By 03/29/2019
After 03/29/2019
Nonmember Student, Undergrad, Grad, Fellow
By 03/29/2019
After 03/29/2019
Member Student, Post-Doc, Fellow
By 03/29/2019
After 03/29/2019


Sonya Dougal, PhD, The New York Academy of Sciences
Lydia Finley, PhD, Memorial Sloan Kettering Cancer Center
Steven Gross, PhD, Weill Cornell Medicine
Costas Lyssiotis, PhD, University of Michigan School of Medicine

Keynote Speaker

William G. Kaelin, Jr., MD, Dana-Farber Cancer Institute; Harvard Medical School


Dafna Bar-Sagi, PhD, NYU Langone Health
Ralph DeBerardinis, MD, PhD, UT Southwestern Medical Center
Marcia Haigis, PhD, Harvard Medical School
Trudy G. Oliver, PhD, Huntsman Cancer Institute, University of Utah
Gary J. Patti, PhD, Washington University in St. Louis
Brent R. Stockwell, PhD,
Columbia University
Benjamin Tu, PhD, UT Southwestern Medical Center

Program Support